本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD

1.27
+0.145012.95%
成交量:4,989.67萬
成交額:6,349.94萬
市值:130.18萬
市盈率:-0.22
高:1.43
開:1.28
低:1.13
收:1.12
52周最高:59.40
52周最低:0.6100
股本:102.91萬
流通股本:94.35萬
量比:4.63
換手率:5288.47%
股息:- -
股息率:- -
每股收益(TTM):-5.8180
每股收益(LYR):-67.2947
淨資產收益率:-42.00%
總資產收益率:-40.11%
市淨率:0.10
市盈率(LYR):-0.02

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/30

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2026/07/15

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/27

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/12/18

SEC問詢函

Form CORRESP - Correspondence
2025/12/18

SEC問詢函

Form CORRESP - Correspondence
2025/12/11

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/12/08

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/11/18

SEC問詢函

Form CORRESP - Correspondence
2025/11/17

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/09/30

SEC問詢函

Form CORRESP - Correspondence
2025/08/20

SEC問詢函

Form CORRESP - Correspondence
2025/04/11

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/24

SEC問詢函

Form CORRESP - Correspondence
2025/01/17

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/11/20

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]